SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-22-001833
Filing Date
2022-03-22
Accepted
2022-03-22 17:00:59
Documents
72
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K phio_i10k-123121.htm   iXBRL 10-K 1077669
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 2046
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER phio_ex3101.htm EX-31.1 10345
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER phio_ex3201.htm EX-32.1 4545
5 GRAPHIC image_001.jpg GRAPHIC 113236
6 GRAPHIC image_002.jpg GRAPHIC 35088
7 GRAPHIC image_003.jpg GRAPHIC 35572
  Complete submission text file 0001683168-22-001833.txt   5538775

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE phio-20211231.xsd EX-101.SCH 39015
9 XBRL CALCULATION FILE phio-20211231_cal.xml EX-101.CAL 53618
10 XBRL DEFINITION FILE phio-20211231_def.xml EX-101.DEF 136827
11 XBRL LABEL FILE phio-20211231_lab.xml EX-101.LAB 326016
12 XBRL PRESENTATION FILE phio-20211231_pre.xml EX-101.PRE 259863
66 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10k-123121_htm.xml XML 730257
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 22760477
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences